ARPA-H Emerging Health Innovators (EHI) Initiative
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Washington, DC
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- ARPA-H-SOL-26-150
- Opportunity Type
- Solicitation
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)
- Posted Date
- Friday, September 25, 2026
- Response Deadline
- Wednesday, February 10, 2027
- PSC Code
- AN41
- Set-Aside
- No Set Aside
- Place of Performance
- Washington, DC, 20005
- Status
- Active
Description
The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) aims to or seeks to ensure ARPA-H identifies and engages early career investigators. To achieve this goal, ARPA-H is soliciting proposals from these researchers and innovators and their organizations to develop cutting-edge biomedical, health, and community-engaged research and innovation. ARPA-H anticipates multiple Other Transaction awards resulting from this announcement Amendment 1: This amendment clarifies the number of submissions that may be submitted by each offeror. See section 2.4 of the ISO. It also updates the solution summary cover sheet and the FAQ.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in Washington, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
